ZEOX — Zeo Scientifix Share Price
0.000.00%
Last trade - 00:00- $14.45m
- $14.39m
- $4.56m
- 52
- 21
- 74
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.38 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -126.08% | ||
Financial Summary
| Year End 31st Oct | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.7 | 3.06 | 5.6 | 6.49 | 4.56 | n/a | n/a | 36.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company. It develops biological therapeutics for the treatment of degenerative diseases and regenerative medicine. Its products are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent and an autologous non-manipulated biologic containing the nanoparticle fraction from a patient’s own peripheral blood (RAAM Products). Its RAAM Products and related services are principally used in the health care industry, administered by doctors and clinics. The Company’s product, Zofin (Organicell Flow), is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs. Patient Pure X, its autologous product, is a non-manipulated biologic containing the nanoparticle fraction from a patient’s own peripheral blood.
Directors
- Albert Mitrani PRE (65)
- Ian Bothwell CFO (60)
- Maria Mitrani CSO (40)
- George Shapiro OTH (59)
- Michael Carbonara IND (37)
- Allen James Meglin IND (62)
- Last Annual
- October 31st, 2023
- Last Interim
- January 31st, 2024
- Incorporated
- August 9th, 2011
- Public Since
- November 8th, 2013
- No. of Shareholders
- 6,000
- No. of Employees
- 23
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 6,332,419
- Address
- 3321 College Avenue, Suite 246, DAVIE, 33328
- Web
- https://organicell.com
- Phone
- +1 3053700482
- Auditors
- WEINBERG & COMPANY PA
Upcoming Events for ZEOX
Similar to ZEOX
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
What is the Zeo Scientifix share price?
As of Today at 18:18 UTC, shares in Zeo Scientifix are trading at $2.48. This share price information is delayed by 15 minutes.
How has the Zeo Scientifix share price performed this year?
Shares in Zeo Scientifix last closed at $2.48 and the price had moved by +26005.26% over the past 365 days. In terms of relative price strength the Zeo Scientifix share price has outperformed the S&P500 Index by +21809.18% over the past year.
What are the analyst and broker recommendations for Zeo Scientifix?
There is no consensus recommendation for this security.
What is the Zeo Scientifix dividend yield?
Zeo Scientifix does not currently pay a dividend.
Does Zeo Scientifix pay a dividend?
Zeo Scientifix does not currently pay a dividend.
When does Zeo Scientifix next pay dividends?
Zeo Scientifix does not currently pay a dividend.
How do I buy Zeo Scientifix shares?
To buy shares in Zeo Scientifix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zeo Scientifix?
As of the previous close price of $2.48, shares in Zeo Scientifix had a market capitalisation of $15.70m.
Where are Zeo Scientifix shares listed?
Here are the trading details for Zeo Scientifix:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ZEOX
What kind of share is Zeo Scientifix?
Based on an overall assessment of its quality, value and momentum Zeo Scientifix is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zeo Scientifix share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Zeo Scientifix share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zeo Scientifix. Over the past six months, its share price has outperformed the S&P500 Index by +81.11%.
As of the last closing price of $2.48, shares in Zeo Scientifix were trading +134.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zeo Scientifix PE Ratio?
The Zeo Scientifix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zeo Scientifix?
Zeo Scientifix's management team is headed by:
- Albert Mitrani - PRE
- Ian Bothwell - CFO
- Maria Mitrani - CSO
- George Shapiro - OTH
- Michael Carbonara - IND
- Allen James Meglin - IND